Share Price and Basic Stock Data
Last Updated: November 28, 2025, 9:57 am
| PEG Ratio | 0.42 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Zen Technologies Ltd operates in the Aerospace & Defense sector and has demonstrated notable revenue growth over recent quarters. For the fiscal year ending March 2023, the company reported sales of ₹161 Cr, a significant increase from ₹54 Cr in March 2022. This upward trend continued into the current fiscal year, with TTM sales standing at ₹671 Cr. Specifically, the company recorded quarterly sales of ₹254 Cr in June 2024 and ₹242 Cr in September 2024, indicating robust demand for its products. The operating profit margin (OPM) has also seen fluctuations, peaking at 50% in June 2023 and averaging around 34% over the last five quarters. Such performance highlights Zen Technologies’ ability to capitalize on the growing defense sector in India, which is projected to expand due to increased government spending and modernization of defense capabilities.
Profitability and Efficiency Metrics
Zen Technologies has consistently improved its profitability metrics, showcasing a net profit of ₹207 Cr for the fiscal year ending March 2025, up from ₹38 Cr in March 2023. The company’s earnings per share (EPS) rose to ₹32.07 for the same period, reflecting strong operational efficiency. The return on equity (ROE) stood at an impressive 24.6%, while the return on capital employed (ROCE) was recorded at 32.9%, indicating effective utilization of capital to generate profits. The interest coverage ratio (ICR) was exceptionally high at 41.63x, suggesting that Zen Technologies has a solid capacity to meet its interest obligations. However, the cash conversion cycle (CCC) of 181 days indicates potential inefficiencies in managing working capital, particularly in inventory and receivables management, which could pose challenges in sustaining profitability amid rising operational costs.
Balance Sheet Strength and Financial Ratios
Zen Technologies presents a robust balance sheet, characterized by a market capitalization of ₹13,080 Cr and a price-to-book value ratio of 7.84x. The company has reported no borrowings, reflecting a debt-free status, which enhances its financial flexibility. Moreover, the current ratio of 6.57x and quick ratio of 6.09x indicate strong liquidity, allowing the firm to cover short-term liabilities without financial strain. The asset turnover ratio of 0.69% suggests a moderate efficiency in utilizing assets to generate revenue. However, the high price-to-earnings (P/E) ratio of 63.2x may indicate that the stock is overvalued relative to its earnings, which could deter potential investors looking for value opportunities. The financial ratios overall demonstrate that Zen Technologies is well-positioned in the market, yet investors should remain cautious regarding its valuation metrics.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Zen Technologies illustrates a balanced distribution among promoters, institutional investors, and the public. As of March 2025, promoters held 49.05% of the company, down from 60.19% in December 2022, indicating a gradual dilution of control. Foreign institutional investors (FIIs) increased their stake to 5.94%, while domestic institutional investors (DIIs) accounted for 7.93%. The public shareholding stood at 37.20%, showing a healthy level of retail investment. The total number of shareholders has surged to 3,25,978, reflecting growing investor confidence in the company. This diversified ownership structure may enhance governance and oversight, but the decline in promoter holding could raise concerns about long-term strategic direction. The increasing presence of institutional investors may bolster credibility and stability in the stock price.
Outlook, Risks, and Final Insight
Zen Technologies is well-positioned to benefit from increasing defense budgets and modernization efforts in India, which bodes well for its future revenue growth. However, the company faces several risks, including potential supply chain disruptions and competition from established global defense firms. Additionally, as the company scales its operations, maintaining profitability could become challenging due to rising operational costs. The high P/E ratio may also deter risk-averse investors, who might perceive the stock as overvalued. In the event of sustained demand for defense products and effective management of operational challenges, Zen Technologies could see significant upside in its stock price. Conversely, failure to manage costs or an unfavorable market environment could lead to a decline in profitability and investor sentiment. The balance between growth opportunities and operational risks will be crucial for Zen Technologies as it navigates the evolving aerospace and defense landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Zen Technologies Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| MTAR Technologies Ltd | 7,773 Cr. | 2,527 | 2,719/1,152 | 168 | 243 | 0.00 % | 10.5 % | 7.51 % | 10.0 |
| DCX Systems Ltd | 2,062 Cr. | 185 | 393/178 | 52.5 | 105 | 0.00 % | 5.10 % | 3.14 % | 2.00 |
| Data Patterns (India) Ltd | 17,040 Cr. | 3,044 | 3,269/1,350 | 73.0 | 275 | 0.27 % | 21.0 % | 15.2 % | 2.00 |
| Paras Defence and Space Technologies Ltd | 5,859 Cr. | 727 | 972/401 | 82.2 | 84.0 | 0.03 % | 16.6 % | 11.8 % | 5.00 |
| Zen Technologies Ltd | 12,704 Cr. | 1,407 | 2,628/945 | 61.4 | 195 | 0.14 % | 32.9 % | 24.6 % | 1.00 |
| Industry Average | 68,416.82 Cr | 1,662.45 | 74.96 | 177.62 | 0.28% | 22.58% | 16.73% | 4.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33 | 21 | 33 | 74 | 132 | 64 | 98 | 136 | 254 | 242 | 142 | 294 | 111 |
| Expenses | 22 | 16 | 25 | 48 | 66 | 42 | 54 | 91 | 151 | 162 | 105 | 199 | 73 |
| Operating Profit | 11 | 5 | 8 | 26 | 66 | 22 | 44 | 45 | 103 | 79 | 37 | 94 | 38 |
| OPM % | 34% | 26% | 25% | 35% | 50% | 34% | 45% | 33% | 41% | 33% | 26% | 32% | 34% |
| Other Income | 2 | 3 | 4 | 0 | 3 | 5 | 4 | 5 | 3 | 8 | 22 | 24 | 20 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 3 | 4 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| Profit before tax | 12 | 7 | 11 | 25 | 67 | 24 | 46 | 47 | 103 | 83 | 53 | 112 | 53 |
| Tax % | 31% | 30% | 29% | 30% | 30% | 29% | 31% | 30% | 28% | 22% | 28% | 24% | 31% |
| Net Profit | 8 | 5 | 8 | 17 | 47 | 17 | 32 | 33 | 74 | 65 | 39 | 85 | 37 |
| EPS in Rs | 1.03 | 0.58 | 0.95 | 2.17 | 5.61 | 2.06 | 3.77 | 3.93 | 8.83 | 7.23 | 4.28 | 9.41 | 4.11 |
Last Updated: August 1, 2025, 9:00 am
Below is a detailed analysis of the quarterly data for Zen Technologies Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 111.00 Cr.. The value appears to be declining and may need further review. It has decreased from 294.00 Cr. (Mar 2025) to 111.00 Cr., marking a decrease of 183.00 Cr..
- For Expenses, as of Jun 2025, the value is 73.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 199.00 Cr. (Mar 2025) to 73.00 Cr., marking a decrease of 126.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 94.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 56.00 Cr..
- For OPM %, as of Jun 2025, the value is 34.00%. The value appears strong and on an upward trend. It has increased from 32.00% (Mar 2025) to 34.00%, marking an increase of 2.00%.
- For Other Income, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 53.00 Cr.. The value appears to be declining and may need further review. It has decreased from 112.00 Cr. (Mar 2025) to 53.00 Cr., marking a decrease of 59.00 Cr..
- For Tax %, as of Jun 2025, the value is 31.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 31.00%, marking an increase of 7.00%.
- For Net Profit, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 85.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 48.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 4.11. The value appears to be declining and may need further review. It has decreased from 9.41 (Mar 2025) to 4.11, marking a decrease of 5.30.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:07 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 46 | 79 | 53 | 62 | 39 | 92 | 147 | 50 | 54 | 161 | 430 | 931 | 671 |
| Expenses | 46 | 58 | 48 | 50 | 41 | 70 | 83 | 42 | 52 | 110 | 253 | 617 | 460 |
| Operating Profit | 1 | 21 | 4 | 12 | -2 | 23 | 64 | 8 | 2 | 51 | 177 | 314 | 211 |
| OPM % | 1% | 27% | 8% | 19% | -5% | 24% | 43% | 16% | 4% | 32% | 41% | 34% | 31% |
| Other Income | 4 | 3 | 5 | 4 | 4 | 3 | 2 | 3 | 5 | 9 | 16 | 58 | 89 |
| Interest | 2 | 2 | 2 | 3 | 2 | 5 | 3 | 1 | 1 | 2 | 2 | 9 | 8 |
| Depreciation | 2 | 2 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 7 | 10 | 12 |
| Profit before tax | 0 | 20 | 3 | 9 | -3 | 17 | 59 | 6 | 2 | 54 | 184 | 352 | 280 |
| Tax % | 18% | 21% | 21% | 20% | -86% | -13% | -3% | 28% | -9% | 30% | 30% | 25% | |
| Net Profit | 0 | 16 | 2 | 7 | -0 | 19 | 61 | 4 | 2 | 38 | 129 | 263 | 207 |
| EPS in Rs | 0.01 | 2.04 | 0.30 | 0.96 | -0.05 | 2.49 | 7.84 | 0.52 | 0.25 | 4.73 | 15.38 | 29.12 | 22.91 |
| Dividend Payout % | 858% | 2% | 33% | 16% | -198% | 12% | 5% | 19% | 39% | 4% | 6% | 7% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -87.50% | 250.00% | -100.00% | 221.05% | -93.44% | -50.00% | 1800.00% | 239.47% | 103.88% |
| Change in YoY Net Profit Growth (%) | 0.00% | 337.50% | -350.00% | 321.05% | -314.50% | 43.44% | 1850.00% | -1560.53% | -135.60% |
Zen Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 45% |
| 3 Years: | 159% |
| TTM: | 43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 34% |
| 3 Years: | 394% |
| TTM: | 46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 36% |
| 5 Years: | 82% |
| 3 Years: | 92% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | 24% |
| Last Year: | 25% |
Last Updated: September 5, 2025, 1:56 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 90 | 276 | 56 | 120 | 212 | 290 | 110 | 128 | 133 | 150 | 143 | 148 |
| Inventory Days | 295 | 225 | 242 | 237 | 1,181 | 496 | 97 | 396 | 625 | 368 | 355 | 42 |
| Days Payable | 63 | 47 | 52 | 89 | 355 | 106 | 48 | 114 | 147 | 33 | 70 | 10 |
| Cash Conversion Cycle | 322 | 455 | 246 | 267 | 1,038 | 681 | 159 | 410 | 612 | 484 | 429 | 181 |
| Working Capital Days | 45 | 119 | -66 | 150 | 59 | 192 | 178 | 543 | 768 | 43 | 152 | 142 |
| ROCE % | 2% | 16% | 3% | 9% | -0% | 14% | 32% | 3% | 1% | 17% | 47% | 33% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 32.07 | 15.45 | 5.39 | 0.25 | 0.39 |
| Diluted EPS (Rs.) | 32.07 | 15.34 | 5.20 | 0.25 | 0.39 |
| Cash EPS (Rs.) | 34.86 | 16.56 | 7.05 | 0.93 | 0.97 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 188.36 | 55.48 | 32.13 | 27.05 | 26.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 188.36 | 55.48 | 32.13 | 27.05 | 26.49 |
| Revenue From Operations / Share (Rs.) | 107.83 | 52.34 | 27.52 | 8.77 | 6.87 |
| PBDIT / Share (Rs.) | 47.84 | 23.29 | 10.04 | 1.25 | 1.31 |
| PBIT / Share (Rs.) | 46.13 | 22.13 | 9.28 | 0.64 | 0.68 |
| PBT / Share (Rs.) | 44.98 | 22.15 | 9.02 | 0.41 | 0.54 |
| Net Profit / Share (Rs.) | 33.16 | 15.41 | 6.28 | 0.32 | 0.34 |
| NP After MI And SOA / Share (Rs.) | 31.04 | 15.22 | 5.38 | 0.24 | 0.39 |
| PBDIT Margin (%) | 44.36 | 44.49 | 36.49 | 14.26 | 19.04 |
| PBIT Margin (%) | 42.77 | 42.29 | 33.72 | 7.33 | 9.97 |
| PBT Margin (%) | 41.71 | 42.32 | 32.77 | 4.73 | 7.98 |
| Net Profit Margin (%) | 30.74 | 29.44 | 22.83 | 3.74 | 5.07 |
| NP After MI And SOA Margin (%) | 28.78 | 29.07 | 19.52 | 2.84 | 5.69 |
| Return on Networth / Equity (%) | 16.47 | 28.50 | 17.70 | 0.95 | 1.52 |
| Return on Capital Employeed (%) | 23.07 | 38.70 | 22.12 | 1.72 | 2.55 |
| Return On Assets (%) | 13.67 | 17.03 | 9.02 | 0.53 | 1.39 |
| Long Term Debt / Equity (X) | 0.02 | 0.00 | 0.00 | 0.02 | 0.01 |
| Total Debt / Equity (X) | 0.03 | 0.00 | 0.02 | 0.06 | 0.01 |
| Asset Turnover Ratio (%) | 0.69 | 0.71 | 0.39 | 0.18 | 0.22 |
| Current Ratio (X) | 6.57 | 2.29 | 2.69 | 3.84 | 13.35 |
| Quick Ratio (X) | 6.09 | 1.66 | 2.34 | 3.49 | 11.84 |
| Inventory Turnover Ratio (X) | 6.75 | 1.58 | 1.93 | 1.00 | 0.64 |
| Dividend Payout Ratio (NP) (%) | 3.20 | 1.30 | 1.85 | 40.05 | 102.21 |
| Dividend Payout Ratio (CP) (%) | 3.03 | 1.21 | 1.62 | 11.66 | 39.44 |
| Earning Retention Ratio (%) | 96.80 | 98.70 | 98.15 | 59.95 | -2.21 |
| Cash Earning Retention Ratio (%) | 96.97 | 98.79 | 98.38 | 88.34 | 60.56 |
| Interest Coverage Ratio (X) | 41.63 | 85.79 | 19.59 | 6.50 | 9.53 |
| Interest Coverage Ratio (Post Tax) (X) | 29.85 | 56.71 | 12.77 | 2.89 | 3.54 |
| Enterprise Value (Cr.) | 12462.13 | 7886.73 | 2457.39 | 1565.48 | 585.38 |
| EV / Net Operating Revenue (X) | 12.80 | 17.93 | 11.23 | 22.44 | 10.71 |
| EV / EBITDA (X) | 28.85 | 40.30 | 30.77 | 157.39 | 56.26 |
| MarketCap / Net Operating Revenue (X) | 13.70 | 18.25 | 11.90 | 23.34 | 11.32 |
| Retention Ratios (%) | 96.79 | 98.69 | 98.14 | 59.94 | -2.21 |
| Price / BV (X) | 7.84 | 17.89 | 10.79 | 7.82 | 3.03 |
| Price / Net Operating Revenue (X) | 13.70 | 18.25 | 11.90 | 23.34 | 11.32 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.00 | 0.01 |
After reviewing the key financial ratios for Zen Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 32.07. This value is within the healthy range. It has increased from 15.45 (Mar 24) to 32.07, marking an increase of 16.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 32.07. This value is within the healthy range. It has increased from 15.34 (Mar 24) to 32.07, marking an increase of 16.73.
- For Cash EPS (Rs.), as of Mar 25, the value is 34.86. This value is within the healthy range. It has increased from 16.56 (Mar 24) to 34.86, marking an increase of 18.30.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 188.36. It has increased from 55.48 (Mar 24) to 188.36, marking an increase of 132.88.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 188.36. It has increased from 55.48 (Mar 24) to 188.36, marking an increase of 132.88.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 107.83. It has increased from 52.34 (Mar 24) to 107.83, marking an increase of 55.49.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 47.84. This value is within the healthy range. It has increased from 23.29 (Mar 24) to 47.84, marking an increase of 24.55.
- For PBIT / Share (Rs.), as of Mar 25, the value is 46.13. This value is within the healthy range. It has increased from 22.13 (Mar 24) to 46.13, marking an increase of 24.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 44.98. This value is within the healthy range. It has increased from 22.15 (Mar 24) to 44.98, marking an increase of 22.83.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 33.16. This value is within the healthy range. It has increased from 15.41 (Mar 24) to 33.16, marking an increase of 17.75.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 31.04. This value is within the healthy range. It has increased from 15.22 (Mar 24) to 31.04, marking an increase of 15.82.
- For PBDIT Margin (%), as of Mar 25, the value is 44.36. This value is within the healthy range. It has decreased from 44.49 (Mar 24) to 44.36, marking a decrease of 0.13.
- For PBIT Margin (%), as of Mar 25, the value is 42.77. This value exceeds the healthy maximum of 20. It has increased from 42.29 (Mar 24) to 42.77, marking an increase of 0.48.
- For PBT Margin (%), as of Mar 25, the value is 41.71. This value is within the healthy range. It has decreased from 42.32 (Mar 24) to 41.71, marking a decrease of 0.61.
- For Net Profit Margin (%), as of Mar 25, the value is 30.74. This value exceeds the healthy maximum of 10. It has increased from 29.44 (Mar 24) to 30.74, marking an increase of 1.30.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 28.78. This value exceeds the healthy maximum of 20. It has decreased from 29.07 (Mar 24) to 28.78, marking a decrease of 0.29.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.47. This value is within the healthy range. It has decreased from 28.50 (Mar 24) to 16.47, marking a decrease of 12.03.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.07. This value is within the healthy range. It has decreased from 38.70 (Mar 24) to 23.07, marking a decrease of 15.63.
- For Return On Assets (%), as of Mar 25, the value is 13.67. This value is within the healthy range. It has decreased from 17.03 (Mar 24) to 13.67, marking a decrease of 3.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.69. It has decreased from 0.71 (Mar 24) to 0.69, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has increased from 2.29 (Mar 24) to 6.57, marking an increase of 4.28.
- For Quick Ratio (X), as of Mar 25, the value is 6.09. This value exceeds the healthy maximum of 2. It has increased from 1.66 (Mar 24) to 6.09, marking an increase of 4.43.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.75. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 6.75, marking an increase of 5.17.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 3.20. This value is below the healthy minimum of 20. It has increased from 1.30 (Mar 24) to 3.20, marking an increase of 1.90.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.03. This value is below the healthy minimum of 20. It has increased from 1.21 (Mar 24) to 3.03, marking an increase of 1.82.
- For Earning Retention Ratio (%), as of Mar 25, the value is 96.80. This value exceeds the healthy maximum of 70. It has decreased from 98.70 (Mar 24) to 96.80, marking a decrease of 1.90.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.97. This value exceeds the healthy maximum of 70. It has decreased from 98.79 (Mar 24) to 96.97, marking a decrease of 1.82.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 41.63. This value is within the healthy range. It has decreased from 85.79 (Mar 24) to 41.63, marking a decrease of 44.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 29.85. This value is within the healthy range. It has decreased from 56.71 (Mar 24) to 29.85, marking a decrease of 26.86.
- For Enterprise Value (Cr.), as of Mar 25, the value is 12,462.13. It has increased from 7,886.73 (Mar 24) to 12,462.13, marking an increase of 4,575.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.80. This value exceeds the healthy maximum of 3. It has decreased from 17.93 (Mar 24) to 12.80, marking a decrease of 5.13.
- For EV / EBITDA (X), as of Mar 25, the value is 28.85. This value exceeds the healthy maximum of 15. It has decreased from 40.30 (Mar 24) to 28.85, marking a decrease of 11.45.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.70. This value exceeds the healthy maximum of 3. It has decreased from 18.25 (Mar 24) to 13.70, marking a decrease of 4.55.
- For Retention Ratios (%), as of Mar 25, the value is 96.79. This value exceeds the healthy maximum of 70. It has decreased from 98.69 (Mar 24) to 96.79, marking a decrease of 1.90.
- For Price / BV (X), as of Mar 25, the value is 7.84. This value exceeds the healthy maximum of 3. It has decreased from 17.89 (Mar 24) to 7.84, marking a decrease of 10.05.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.70. This value exceeds the healthy maximum of 3. It has decreased from 18.25 (Mar 24) to 13.70, marking a decrease of 4.55.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zen Technologies Ltd:
- Net Profit Margin: 30.74%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.07% (Industry Average ROCE: 22.58%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.47% (Industry Average ROE: 16.73%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 29.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 6.09
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 61.4 (Industry average Stock P/E: 74.96)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 30.74%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Aerospace & Defense | B-42, Industrial Estate, Hyderabad Telangana 500018 | info@zentechnologies.com http://www.zentechnologies.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Atluri | Chairman & Managing Director |
| Mr. Kishore Dutt Atluri | Founder & Joint Managing Director |
| Ms. Shilpa Choudari | Whole Time Director |
| Ms. Sirisha Chintapalli | Independent Director |
| Mr. Sanjay Vijay Singh Jesrani | Independent Director |
| Dr. Ajay Kumar Singh | Independent Director |
| Mr. Durga Prasad Kode | Independent Director |